Shishir Singh

6PUBLICATIONS
19CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Medical parasitologyMedicinal and biomolecular chemistry not elsewhere classifiedMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2025
Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics.

Shishir Singh, Rajeev Nema, Monisha Banerjee

|Jun 19, 2024
The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease.

Daniela Guisado, Sayali Talware, Xiaoli Wang

|Jan 05, 2023
ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence.

Shishir Singh, Mateo Murillo-León, Niklas Sebastian Endres

|Apr 06, 2019
Author Correction: Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.

Mateo Murillo-León, Urs B Müller, Ines Zimmermann

|Mar 16, 2019
Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.

Mateo Murillo-León, Urs B Müller, Ines Zimmermann

Pageof 1